Poland· PL-100173708
Human Albumin 200 g/l Takeda
A albumin product containing albuminum humanum, registered in Poland by Takeda Pharma Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Albumin is registered in 13 of 19 countries.
Countries holding a registration under ATC B05AA01 (albumin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Albumin · ATC B05AA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Albuminum humanum
- Manufacturer
- Takeda Pharma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B05AA01
- ATC class
- Albumin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990019991
- gtin05909990020003
- gtin05909990020041
- gtin05909990020058
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AA01
Albumin, as other registers publish it.
- FinlandAlbiominBiotest Pharma GmbH
- PolandAlbiomin 20%Biotest Pharma GmbH
- IcelandAlbumanProthya Biosolutions Netherlands B.V.
- FinlandAlbumanProthya Biosolutions Netherlands B.V.
- FinlandAlbumanProthya Biosolutions Netherlands B.V.
- NetherlandsAlbuman 200 g/l oplossing voor infusieProthya Biosolutions Netherlands B.V.
- NetherlandsAlbuman 40 g/l oplossing voor infusieProthya Biosolutions Netherlands B.V.
- DenmarkAlbumin "Baxalta"Baxalta Innovations GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fbdb1958-71b6-435a-a596-4b0226cf33d0 GET /v1/drugs/fbdb1958-71b6-435a-a596-4b0226cf33d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "200 g/l",
"packaging": "05909990019991 ¦ Rp ¦ 34548\n1 fiol. 50 ml\n05909990020003 ¦ Rp ¦ 34549\n70 fiol. 50 ml\n05909990020041 ¦ Rp ¦ 34550\n1 fiol. 100 ml\n05909990020058 ¦ Rp ¦ 34551\n56 fiol. 100 ml",
"substance": "Albuminum humanum 200 g/l",
"common_name": "Albuminum humanum",
"pl_product_id": "100173708",
"pozwolenie_nr": "12596",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about albumin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.